J&J OneTouch Select Plus Simple
The technology used in the J&J OneTouch Select Plus Simple, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||★★ Recommendation||Recent clinical validation; recent protocol|
|MDR Criteria||Self-measurement||Published evidence|
Katz LB, Grady M, Stewart L, Cameron H, Anderson PA, Desai A. Patient and Health-care Professional Satisfaction with a New, Simple, High Accuracy Blood Glucose Meter with Color Range Indicator. Indian J Endocrinol Metab. 2017 Mar-Apr;21(2):322-8. Epub: 2017 April 21. doi: 10.4103/2230-8210.202030. PMID: 28459033. Available from: PMC5367238.
15197:2013 - Pass General population
Katz LB, Grady M, Setford J, Levy BL. OneTouch Blood Glucose Monitoring Systems – Impact of New Technologies on the Efficacy of Self-monitoring Blood Glucose US Endocrinology. 2018 Jan;14(Suppl 1):2-8. Epub: 2018 Jan 22. Available from: www.touchendocrinology.com.
Given the struggles that many patients have with ongoing adherence, motivation, health literacy and/or numeracy, the newer BGMS features described in this article represent important tools which may help HCPs better communicate with their patients on how to both understand their BG data and encourage appropriate self-management from their patients.